Sven Staffeldt & Jörg Hagemann (Hg.). 2014. Pragmatiktheorien. Analysen im Vergleich
Walczak Gregor
doaj +1 more source
Carelizumab and rivoceranib for advanced extramammary Paget's disease: an investigator-initiated multicenter, single-arm, phase II trial. [PDF]
Zhang S +6 more
europepmc +1 more source
Johannes Heil. 2012. Die Rhetorik des Spitzensports
Beljutin Roman
doaj +1 more source
Antibody-drug conjugate (disitamab vedotin) therapy targeting HER2-low or higher advanced extramammary Paget's disease. [PDF]
Zhang S +8 more
europepmc +1 more source
Josef Klein. 2014. Grundlagen der Politolinguistik. Ausgewählte Aufsätze
Pappert Steffen
doaj +1 more source
Selinexor plus tislelizumab in patients with relapsed/refractory natural killer/T-cell lymphoma after failure of PD-1 blockade: the phase 1b TOUCH trial. [PDF]
Liu C +7 more
europepmc +1 more source
Gredig Andi
doaj +1 more source
Enhanced efficacy and long-term survival with SBRT plus PD-1 inhibitors versus SBRT alone in unresectable HCC: a multicenter PSM study. [PDF]
Wei X +10 more
europepmc +1 more source
Radiation-Free Therapy for the Initial Treatment of Good Prognosis Early Non-Bulky Hodgkin Lymphoma, Defined by a Low Metabolic Tumor Volume and a Negative Interim PET After 2 Chemotherapy Cycles: The RAFTING Trial Protocol. [PDF]
Filonenko K +21 more
europepmc +1 more source
Patterns of progression and survival in patients with mismatch repair deficient/ microsatellite instability- high metastatic colorectal cancer treated with immunotherapy. [PDF]
LaPelusa M +19 more
europepmc +1 more source

